NHS National Pharmaceuticals Transition 2022_1

Tender description

NHS National Pharmaceuticals Transition 2022_1<br/>Potential periods of call-offs under the<br/>framework agreement:<br/>Transition:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months)<br/>Oral (plus non-parenteral) Products: All<br/>regions: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>Hospital Only Products:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6<br/>months) Lot 1: Lot 1 - CM/PHG/21/5637/00 Transition products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/00<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 29/07/2022 to30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 2: Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/01<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 3: Lot 3 - CM/PHG/21/5637/02 Hospital Only Products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/02<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Hospital Only Products: CESW:29/07/2022 to 30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 1: Lot 1 - CM/PHG/21/5637/00 Transition products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/00<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 29/07/2022 to30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 2: Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/01<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Lot 3: Lot 3 - CM/PHG/21/5637/02 Hospital Only Products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1<br/>Offer reference number: CM/PHG/21/5637/02<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Hospital Only Products: CESW:29/07/2022 to 30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents